Table 1 Baseline demographic status and comorbidity compared between hypertonic solution cohort and comparison cohort
Variable | PD patients | p-value | |
|---|---|---|---|
Comparison cohort | HPD cohort | ||
N = 296 (%) | N = 203 (%) | ||
Age, mean (SD) years | 50.9 (17.1) | 56.1 (15.8) | 0.0007 |
≦30 | 41 (13.9) | 12 (5.9) | 0.0030 |
31-50 | 107 (36.1) | 59 (29.1) | |
51-70 | 105 (35.5) | 96 (47.3) | |
>70 | 43 (14.5) | 36 (17.7) | |
Sex | 0.3500 | ||
Female | 170 (57.4) | 108 (53.2) | |
Male | 126 (42.6) | 95 (46.8) | |
Comorbidity | |||
Hypertension | 247 (83.4) | 182 (89.7) | 0.0498 |
Ischemic heart disease | 81 (27.4) | 70 (34.5) | 0.0891 |
Diabetes | 79 (26.7) | 89 (43.8) | <0.0001 |
DM foot ulcer | 5 (1.7) | 5 (2.5) | 0.5445 |
DM neuropathy | 13 (4.4) | 19 (9.4) | 0.0261 |
Heart failure | 61 (20.6) | 60 (29.6) | 0.0220 |
Peripheral vascular disease | 5 (1.7) | 5 (2.5) | 0.5445 |
Hyperparathyroidism | 7 (2.4) | 8 (3.9) | 0.3111 |
Follow-up duration, mean (SD) | 4.2 (2.9) | 3.1 (2.8) | <0.0001 |
DM duration, mean (SD) | 9.8 (3.3) | 9.7 (3.6) | 0.8736 |